m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG01023)
Name
4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide
Synonyms
CHEMBL272622; SCHEMBL5312313; JAKLWQFGJXPTHN-UHFFFAOYSA-N; BDBM50371742
    Click to Show/Hide
Status
Investigative
Structure
Formula
C13H11FN2O2S
InChI
1S/C13H11FN2O2S/c14-11-3-5-12(6-4-11)16-9-10-1-7-13(8-2-10)19(15,17)18/h1-9H,(H2,15,17,18)
InChIKey
JAKLWQFGJXPTHN-UHFFFAOYSA-N
PubChem CID
21862753
TTD Drug ID
D0Y9ZO
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Prostaglandin G/H synthase 2 (COX-2)
Methyltransferase-like 3 (METTL3)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Prostaglandin G/H synthase 2 (COX-2) is a therapeutic target for 4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide. The Methyltransferase-like 3 (METTL3) has potential in affecting the response of 4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide through regulating the expression of Prostaglandin G/H synthase 2 (COX-2). [1], [2]
References
Ref 1 METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophys Res Commun. 2019 Aug 13;516(1):22-27. doi: 10.1016/j.bbrc.2019.05.168. Epub 2019 Jun 8.
Ref 2 Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides. Bioorg Med Chem. 2008 Mar 1;16(5):2697-706. doi: 10.1016/j.bmc.2007.11.033. Epub 2007 Nov 17.